Connection

Marijn Speeckaert to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Marijn Speeckaert has written about Antibodies, Monoclonal, Humanized.
Marijn Speeckaert
Connection Strength
0.035
Antibodies, Monoclonal, Humanized
  1. Secukinumab: IL-17A inhibition to treat psoriatic arthritis. Drugs Today (Barc). 2016 Nov; 52(11):607-616.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.